| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G9008 |
Coordinated care fee, physician coordinated care oversight services |
1,301 |
1,023 |
$46K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,272 |
1,241 |
$708.48 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
322 |
313 |
$88.33 |
| 86703 |
|
612 |
608 |
$36.03 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
825 |
820 |
$17.78 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,520 |
1,261 |
$9.50 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,589 |
1,576 |
$6.12 |
| 80061 |
Lipid panel |
1,446 |
1,435 |
$5.77 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,659 |
1,535 |
$4.84 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,116 |
1,069 |
$3.63 |
| 80076 |
|
638 |
636 |
$3.19 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
21 |
12 |
$0.00 |
| 82274 |
|
110 |
110 |
$0.00 |
| 3078F |
|
441 |
421 |
$0.00 |
| 99442 |
|
1,353 |
1,292 |
$0.00 |
| 82540 |
|
89 |
87 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
45 |
45 |
$0.00 |
| 86705 |
|
55 |
55 |
$0.00 |
| 84439 |
|
27 |
27 |
$0.00 |
| 3077F |
|
19 |
17 |
$0.00 |
| 87340 |
|
414 |
412 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,268 |
2,876 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
524 |
520 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
1,021 |
869 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
244 |
240 |
$0.00 |
| 3074F |
|
375 |
357 |
$0.00 |
| 85027 |
|
100 |
90 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
256 |
255 |
$0.00 |
| 3044F |
|
166 |
166 |
$0.00 |
| 86706 |
|
117 |
117 |
$0.00 |
| 3075F |
|
60 |
60 |
$0.00 |
| 83735 |
|
17 |
13 |
$0.00 |
| 1220F |
|
77 |
77 |
$0.00 |
| 82043 |
|
89 |
87 |
$0.00 |
| 1111F |
|
164 |
162 |
$0.00 |
| 99441 |
|
100 |
96 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
46 |
46 |
$0.00 |
| 4450F |
|
26 |
26 |
$0.00 |
| 3079F |
|
45 |
45 |
$0.00 |
| 81001 |
|
13 |
12 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
43 |
43 |
$0.00 |